Your browser doesn't support javascript.
Changes in all-cause and cause-specific excess mortality before and after the Omicron outbreak of COVID-19 in Hong Kong.
Chong, Ka Chun; Chan, Paul Ks; Hung, Chi Tim; Wong, Carlos Kh; Xiong, Xi; Wei, Yuchen; Zhao, Shi; Guo, Zihao; Wang, Huwen; Yam, Carrie Hk; Chow, Tsz Yu; Li, Conglu; Jiang, Xiaoting; Leung, Shuk Yu; Kwok, Ka Li; Yeoh, Eng Kiong; Li, Kehang.
  • Chong KC; School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Chan PK; Clinical Trials and Biostatistics Laboratory, Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China.
  • Hung CT; Department of Microbiology, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Wong CK; School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Xiong X; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Wei Y; Department of Family Medicine and Primary Care, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Zhao S; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Guo Z; School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Wang H; School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Yam CH; Clinical Trials and Biostatistics Laboratory, Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China.
  • Chow TY; School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Li C; School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Jiang X; School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Leung SY; School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Kwok KL; School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Yeoh EK; School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Li K; Department of Paediatrics, Kwong Wah Hospital, Hong Kong, China.
J Glob Health ; 13: 06017, 2023 Apr 28.
Article in English | MEDLINE | ID: covidwho-2293444
ABSTRACT

Background:

While coronavirus 2019 (COVID-19) deaths were generally underestimated in many countries, Hong Kong may show a different trend of excess mortality due to stringent measures, especially for deaths related to respiratory diseases. Nevertheless, the Omicron outbreak in Hong Kong evolved into a territory-wide transmission, similar to other settings such as Singapore, South Korea, and recently, mainland China. We hypothesized that the excess mortality would differ substantially before and after the Omicron outbreak.

Methods:

We conducted a time-series analysis of daily deaths stratified by age, reported causes, and epidemic wave. We determined the excess mortality from the difference between observed and expected mortality from 23 January 2020 to 1 June 2022 by fitting mortality data from 2013 to 2019.

Results:

During the early phase of the pandemic, the estimated excess mortality was -19.92 (95% confidence interval (CI) = -29.09, -10.75) and -115.57 (95% CI = -161.34, -69.79) per 100 000 population overall and for the elderly, respectively. However, the overall excess mortality rate was 234.08 (95% CI = 224.66, 243.50) per 100 000 population overall and as high as 928.09 (95% CI = 885.14, 971.04) per 100 000 population for the elderly during the Omicron epidemic. We generally observed negative excess mortality rates of non-COVID-19 respiratory diseases before and after the Omicron outbreak. In contrast, increases in excess mortality were generally reported in non-respiratory diseases after the Omicron outbreak.

Conclusions:

Our results highlighted the averted mortality before 2022 among the elderly and patients with non-COVID-19 respiratory diseases, due to indirect benefits from stringent non-pharmaceutical interventions. The high excess mortality during the Omicron epidemic demonstrated a significant impact from the surge of COVID-19 infections in a SARS-CoV-2 infection-naive population, particularly evident in the elderly group.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiration Disorders / COVID-19 Type of study: Experimental Studies / Observational study Topics: Variants Limits: Aged / Humans Country/Region as subject: Asia Language: English Journal: J Glob Health Year: 2023 Document Type: Article Affiliation country: Jogh.13.06017

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiration Disorders / COVID-19 Type of study: Experimental Studies / Observational study Topics: Variants Limits: Aged / Humans Country/Region as subject: Asia Language: English Journal: J Glob Health Year: 2023 Document Type: Article Affiliation country: Jogh.13.06017